It’s easy to say you are patient centred – until you are asked to spell out what that means in terms of your processes and practice. Last summer 11 patient groups invited nine pharmaceutical companies [more]
Cancer-related fatigue affects many people, before, during and after treatment. It can have a seriously debilitating impact on lives, but effective interventions have so far proved hard to find. Sophie Fessl explores what might be [more]
The European Oncology Nursing Society is a pan-European organisation dedicated to the support and development of cancer nursing. It recently completed a landmark research project – RECaN – aimed at increasing recognition of the value [more]
Recently, Allison and Honjo have been awarded with the Nobel prize for their findings leading to the new cancer treatment approaches known as immune checkpoint inhibitors (ICIs). Thanks to these discoveries in fact, the management of [more]
In patients with early cervical cancer, minimally invasive surgery is likely not the best option, according to two studies with “alarming data” appearing in the latest issue of the New England Journal of Medicine. “Minimally [more]
With the goal of “saving additional 250,000 Europeans every year”, EuropaColon decided to expand its activities to all digestive cancers: oesophageal, stomach, colon, rectum, pancreas and rare digestive cancers. Digestive Cancers Europe, as the new [more]
“Tobacco control efforts implemented since the 1960s will continue to reduce lung cancer rates well into the next half-century. Additional prevention and cessation efforts will be required to sustain and expand these gains to further [more]
After the European Medicines Agency (EMA) approves a new cancer drug, reimbursement decisions by each country’s health authorities can take up to one year, with wide variations between countries. according to a study just presented [more]
“At one year from initiation of TAM, plasma measurements show that a substantial proportion of premenopausal patients are not adequately adherent to this treatment. Poorly-adherent patients could benefit from metabolic and pharmacogenetic investigations. Identification of [more]
There is too little awareness about cancer associated thrombosis: this is the main result of the first survey on awareness of cancer related thrombosis presented by ECPC (the European Cancer Patient Coalition) for the World Thrombosis [more]
American James Allison and Japanese Tasuku Honjo have been awarded the 2018 Nobel Prize for Physiology or Medicine thanks to their findings leading to recent new approaches in cancer treatment. James Allison, born in Texas [more]
The most commonly prescribed class of immunotherapies (called ICIs, immune checkpoint inhibitors) are not free from fulminant and fatal toxic side effects; the researchers of the Vanderbilt-Ingram Cancer Center recently evaluated their toxicities, publishing the [more]
While holidaying on the Greek island of Ithaca, where the Odyssey ended, I met a man of my age and my country who had just finished his treatment for colorectal cancer. He now lives on [more]